Cited by 372Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsOpioid Use Disorder Treatment

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Reus, Victor I., Fochtmann, Laura J., Bukstein, Oscar, Eyler, A. Evan, Hilty, Donald M., Horvitz-Lennon, Marcela, Mahoney, Jane, Pasic, Jagoda, Weaver, Michael, Wills, Cheryl D., McIntyre, Jack, Kidd, Jeremy, Yager, Joel, Hong, Seung-Hee·2018·American Journal of Psychiatry

DOI 10.1176/appi.ajp.2017.1750101

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2017.1750101

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Clinical Practice Guidelines We Can Trust
Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,146
Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,366
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220
Economic costs of excessive alcohol consumption in the U.S., 2006
Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.045 · Cited by 1,041 · cited 1×
“According to a 2006 Centers for Disease Control and Prevention-sponsored study (Bouchery et al., 2011), AUD and its sequelae cost the U.S. $223.5 billion annually and account for significant excessmortality (Kendler etal., 2016).”
MethodInfluential
Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
Mark, T. L., Kassed, C. A., Vandivort-Warren, R., Levit, K. R., & Kranzler, H. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.018 · Cited by 246
Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group.
(1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.631 · Cited by 205

Flagged first, then by citations

Show all 20 references

Sorted by citations

Items 301–371 of 371

References
(2019) · Elsevier eBooks · doi:10.1016/b978-0-323-68017-2.16001-6
The Changing Landscape of Substance Use Disorders
(2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17201
Chapter 30: Toxicology
Chyka, P. A. (2020) · The American Pharmacists Association eBooks · doi:10.21019/9781582123417.ch30
Alcohol Use Disorder
Colón-Rivera, H., Aoun, E. G., & Vaezazizi, L. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75486-6.00004-7
Recommendations from Current German, British, American, and Australian Guidelines on Alcohol Treatment
Proebstl, L., & Pogarell, O. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_462
Short-term Naltrexone Use Associated with Delayed-Onset Fever and Hepatotoxicity
Hsu, C.-C., Ku, Y.-H., & Chen, H. (2022) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_33_22
Intramuscular, extended-release naltrexone inadvertently administered in the deltoid muscle: A case report
Deaney, M. A., & Terasaki, D. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.05.010
Alcohol Use Disorder
Celik, M. A., & Fuehrlein, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00027-0
Prevalence and Associated Risk Factors Among Patients With Alcohol Use Disorder During COVID-19: Analysis from the National Survey on Drug Use and HealthPreprint
Başer, O., Zeng, Y., & Baser, I. E. (2023) · Research Square · doi:10.21203/rs.3.rs-3367285/v1
Progetto di Disassuefazione Alcolica. Aspetti organizzativi e clinici: dall'Ospedale al Territorio
Merlini, R., & Fiorentino, G. (2023) · MISSION · doi:10.3280/mis61-2022oa16476
Transcranial Magnetic Stimulation in Addiction Therapies
Sanna, A., & Diana, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_19
Alcohol Use Disorder
Spoleti, C., George, G., & Marpuri, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_15
Associations between mental health & substance use treatment and alcohol use progression and recovery among US women drinkers
Young, A. S., Reboussin, B. A., Riehm, K. E., Mojtabai, R., Green, K. M., O’Gorman, E. T., Susukida, R., Amin‐Esmaeili, M., & Crum, R. M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306820
Substance Use Disorders
Powers, J., Weyer, G. W., Conrad, R. C., Simon, K. M., & Bukstein, O. (2024) · Springer eBooks · doi:10.1007/978-3-031-54281-7_19
Self-citation
Analysis of Ohio Advanced Practice Registered Nurses’ Rate of Prescribing Naltrexone for Patients With Alcohol Use Disorder Since Elimination of the X-Waiver
Wiggins, M., Smith, A. M., & Helsabeck, N. P. (2024) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903241271273
Implementing an Updated Alcohol Withdrawal Symptom Management Order Set Focused on Patient Safety
Lorbiecki, M., Gidal, A., Hagle, M. E., Smith, T., Ragen-Pease, K., Peterson, K., Matye, M., Kowol, M.-A., & Lampe, E. (2024) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000584
A Novel Interactive Video Module for Providers Improves Knowledge of Best-Practices for Treating Alcohol Use Disorder
Twohig, P., Slocum, Z. P., Balasanova, A., Khoury, N., Ashford, A., Scholten, K., Warner, J., Gallagher, J., & Peeraphatdit, T. (2024) · Graduate Medical Education Research Journal · doi:10.32873/unmc.dc.gmerj.6.2.005
Technology-Assisted Treatment of Alcohol Use Disorder
Cabrera, D., & Khan, M. (2024) · Psychiatry update · doi:10.1007/978-3-031-73553-0_9
Pharmacotherapies for Alcohol Use Disorder
Makovkina, E. (2024) · Psychiatry update · doi:10.1007/978-3-031-73553-0_7
Chapter 15. Pain and Substance Use Disorders
(2023) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379989.lg15
Chapter 21. Substance Use Disorders in the Medical Setting
Sharma, S., Haddad, S. E., & Suzuki, J. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378869.lg21
Perturbations in the gut microbiome of C57BL/6 mice by the sobriety aid Antabuse® (disulfiram)
Evans, S. E., Valentine, M. E., Gallimore, F., Meka, Y., Koehler, S. I., Yu, H. D., Valentovic, M. A., & Long, T. E. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae305
Values in Alcohol Use Disorders
Soares, M. J. F. R., & Messas, G. P. (2024) · Springer eBooks · doi:10.1007/978-3-031-72219-6_36
Substance Use Disorders
Stead, V. E., Lumb, A. B., Brasch, J. S., & MacKillop, J. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009086264.013
Subacute polyneuropathy of a patient under treatment with disulfiram, suffering from alcohol use disorder
Péter-Zoltán, M., Klára, I., Szász, J. A., Emil, S., & Szatmári, S. (2022) · Orvostudományi Értesítö · doi:10.2478/orvtudert-2022-0016
A Structured Approach to the Prevention of Psychoactive Substances Use in Vulnerable Populations and the Therapeutic Interventions in the Case of Patients Diagnosed with Substance Use Disorders – A Romanian Society-focused Perspective
Voicu, V. A., & Vasiliu, O. (2025) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2025.128.2.8
Frequency of Relapse Rate after Treatment of Patients Addicted with Drugs Abuse (Opioids)
Ather, A., Hamdani, S. M. A., & Jan, H. T. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i2.622
The use of baclofen to reduce alcohol-attributable hospitalizations and emergency department admissions
Huang, M., Tsai, K., & Shao, Y. J. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.03.002
Using inpatient addiction consult service via telehealth to improve pharmacotherapy initiation: An observational study
Deng, H., Nikravesh, M., Raheemullah, A., & Tate, S. (2025) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x251319851
Ethanol
Yoon, J. T., Devanney, J., & Fehnel, C. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00444-9
Antidepressants in Alcohol Use Disorder: Balancing Evidence, Clinical Nuance, and the Risks of Deprescribing
Bahji, A. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00661-8
Factors influencing the achievement of remission in patients with alcohol dependence and concomitant psychological disorders
Kardashian, R. A., Efremov, A. A., Никифоров, И. А., & Korovyakov, A. V. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512506121
Current Pharmacotherapies for Alcohol Use Disorder in Italy: From Neurobiological Targets to Clinical Practice
Mastrostefano, A., Greco, G., Bacco, C. D., Davini, F., Polito, G., Carnevale, E., Anastasi, G., & Terracina, S. A. (2025) · Targets · doi:10.3390/targets3030024
The epidemiology of alcohol consumption is associated with risky behaviors on the West Bank: a cross-sectional study
Abed, M., Nairat, M., Assaf, I., Salous, A., Abdul‐Hafez, H. A., Abuawad, M., Alqub, M., Hanani, A. A., & Damiri, B. (2025) · Drugs Habits and Social Policy · doi:10.1108/dhs-12-2024-0047
RETRACTED CHAPTER: Alcohol Use Disorders
Orsolini, L., Volgare, R., Francesconi, G., Martinotti, G., & Volpe, U. (2025) · Springer eBooks · doi:10.1007/978-3-031-99720-4_21
Retracted
Trends, timing, and predictors of alcohol use disorder treatment among US adult cancer survivors
Lai, J., Avanceña, A. L. V., Nguyen, M. H. K., Zigler, C. M., Velasquez, M. M., Frei, C. R., & Pignone, M. P. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70033
Convergence of sociodemographic, clinical, regulatory, and quality characteristics in pharmacotherapeutic management of alcohol use disorder: a scoping review protocol
Pinheiro, R. V. B., Correia, T., de Oliveira, H. A., & Wagner, G. A. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02889-x
Chapter 3. Alcohol Use Disorder
Kranzler, H. R., Knapp, C. M., & Hartwell, E. E. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg03
A Potential Case of Acamprosate-Induced Syncope in an Elderly Patient: A Case Report and Literature Review
Khodari, K. A., Troung, H. H., Keratishvili, D., SOROUR, L., Anagreh, T., & Khodari, M. A. (2025) · Cureus · doi:10.7759/cureus.99283
The Effect of the Religious Leader Educator Training Program in Combating Substance Abuse on Awareness Building and Self-Efficacy in Turkey
Altın, A., & Avci, İ. A. (2025) · Journal of Religion and Health · doi:10.1007/s10943-025-02517-x
Additional file 2 of Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence
Botwright, S., Sutawong, J., Kingkaew, P., Anothaisintawee, T., Dabak, S. V., Suwanpanich, C., Promchit, N., Kampang, R., & Isaranuwatchai, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611592
Additional file 1 of Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence
Botwright, S., Sutawong, J., Kingkaew, P., Anothaisintawee, T., Dabak, S. V., Suwanpanich, C., Promchit, N., Kampang, R., & Isaranuwatchai, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611589
Additional file 3 of Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence
Botwright, S., Sutawong, J., Kingkaew, P., Anothaisintawee, T., Dabak, S. V., Suwanpanich, C., Promchit, N., Kampang, R., & Isaranuwatchai, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611595
Additional file 5 of Which interventions for alcohol use should be included in a universal healthcare benefit package? An umbrella review of targeted interventions to address harmful drinking and dependence
Botwright, S., Sutawong, J., Kingkaew, P., Anothaisintawee, T., Dabak, S. V., Suwanpanich, C., Promchit, N., Kampang, R., & Isaranuwatchai, W. (2023) · Figshare · doi:10.6084/m9.figshare.22611601
Rethinking AUD Pharmacotherapy Gaps in Primary Care: A Systems-Level Imperative Beyond Diagnosis
Rattanapitoon, S. K., Padchasuwan, N. H., La, N., & Rattanapitoon, N. K. (2025) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-025-09985-9
A Study of Factors Associated with Relapse in Alcohol Dependence and Intragroup Comparison of Factors Leading to Early vs Late Relapse
Preetinanda, P., Singisetti, S., Garapati, A., Nukala, S., Vasireddy, N., Sanapala, V., & Tata, R. S. (2025) · Indian Journal of Private Psychiatry · doi:10.5005/jp-journals-10067-0195
Addiction in Gastrointestinal and Liver Disorders
Deutsch‐Link, S., Byers, I. S., Gu, H., & Arab, J. P. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003925 · Cited by 1
Educational video module for increasing treatment rates for alcohol use disorders in inpatients
Adnyana, I. M. D. M. (2026) · World Journal of Hepatology · doi:10.4254/wjh.v18.i1.115013
Analysis of the Adverse Event Profiles of Medications for Alcohol Use Disorder: Insights from a Japanese Pharmacovigilance Database
Kotake, K., Fujiwara, M., & Shimizu, T. (2026) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-026-01638-y
Patterns and predictors of the transition between minimally adequate treatment and effective treatment coverage for mental disorders: results from the World Mental Health Survey
Ae, K., Pozuelo, J. R., Harris, M., Stein, D. J., Viana, M. C., Hwang, I. H., Kessler, T. L., Manoukian, S. M., Sampson, N. A., Aguilar‐Gaxiola, S., et al. (2026) · International Journal of Mental Health Systems · doi:10.1186/s13033-026-00698-w
Concerns About Gabapentinoids in Psychiatric Practice
Kverno, K. S. (2026) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20260205-01
Real‐World Pharmacological Management of Alcohol Dependence in a Nepalese Rehabilitation Center: Prospective Cohort Study
Singh, S. K., Marasine, N. R., Sankhi, S., Bhandari, K., & Bhuju, G. B. (2026) · Public Health Challenges · doi:10.1002/puh2.70199
Addiction psychiatry: where we are and challenges in the UK
Lingford-Hughes, A. R. (2026) · International Review of Psychiatry · doi:10.1080/09540261.2026.2627509
Are polygenic scores for psychiatric and substance use outcomes “ready” for clinical application? Current state and next steps
Dick, D. M., Dash, G. F., Hung, I., & Horgan, A. (2026) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000415 · Cited by 1
Medicaid Managed Care Plan Alignment With State Substance Use Disorder Treatment Coverage Requirements
Feltus, S. R., Andrews, C. M., Peterson, L., Grogan, C. M., Abraham, A. J., Hinds, O. M., & Stewart, M. T. (2026) · Milbank Quarterly · doi:10.1111/1468-0009.70083
Emergency Department Management of Perinatal Substance Use Disorder: Discussing Gaps and Opportunities for Resident Education
Reyes, J., Ager, E. E., Ahmed, Z., Follman, S., Gonzalez, A., Quinley, K., & Agarwal, A. (2026) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2026.02.019
A Membrane‐Centric Plasma Lipidomic Signature of Response to Long‐Acting Naltrexone in Alcohol Use Disorder
Huang, L., Zhou, B., Ou, Q., Yin, J., Tian, X., & Zhou, X. (2026) · Addiction Biology · doi:10.1111/adb.70165
Chapter 10. Treatment of Substance Use Disorders
Olagunju, A. T., & Slavin‐Stewart, C. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551913.lg10
Chapter 5. Alcohol Use and Use Disorder Among Older Adults
Gopalakrishna, G., Joshi, P., & Patel, N. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551968.lg05
Therapeutic Effects of Dihydromyricetin on Wholly Alcohol-Attributed Conditions: A Systematic Review
Skinner, S. G., Matcha, S., & Davies, D. L. (2026) · Nutrients · doi:10.3390/nu18142221
Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment
Caputo, F., Vignoli, T., Lungaro, L., Costanzini, A., Casabianca, A., Caio, G., Testino, G., Addolorato, G., & GIORGIO, R. D. (2026) · Alcohol and Alcoholism · doi:10.1093/alcalc/agag052
Alcohol‐Induced Early‐Stage Liver Injury Contributes to Increases in Voluntary Alcohol Intake and Cognitive Deficits in Mice
Skinner, S. G., Aleman, E. G., Rivera, J., Kalapatapu, N., Kantilal, D., Davies, D. L., & Asatryan, L. (2026) · Alcohol, clinical & experimental research · doi:10.1111/acer.70391
Naltrexone
Breckling, M. N., & Streett, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44037-3.00667-9
Behavioral and Psychosocial Predictors of Treatment Response in Emergency Psychiatric Admissions for Substance Use Disorders in a Socioeconomically Vulnerable Region of Southeastern Romania: A Five-Year Retrospective Study
Ragea, I.-V., Mitincu-Caramfil, S.-D., Rusu-Negraia, M., Pleșea-Condratovici, C., Ardeleanu, V., Roșca, R.-O., Drăguș, L., & Moroianu, L.-A. (2026) · Behavioral Sciences · doi:10.3390/bs16091496
Serotonergic Antidepressants in Concurrent Disorders: A Call for Accelerated Research and Interdisciplinary Collaboration
Sloan, M. E., Bahji, A., Crockford, D. N., Danilewitz, M., Jutras‐Aswad, D., & Tang, V. M. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437261483871
Safety and Efficacy of Rapid-Titration Naltrexone/Bupropion for Alcohol Use Disorder With Multimorbidity
Liang, C.-W., Lee, Y., & Wang, J.-K. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002261
Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats
Lodetti, G., Redivo, H., Teixeira, A. G., de Farias, A. C. S., Pacagnan, L. D. O., Rohling, J. P. V., Endler, A. T., Zampronio, E. P., de Souza, D. D. P., Assis, V. F., et al. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03287-w
Repurposing incretin-based therapies for alcohol use disorder: a systematic review of efficacy and safety relative to standard pharmacotherapies in a recent comparative context
Alevizopoulos, A. G., Vasilakos, V., Kritikos, I., Alevizopoulou, M., Korompoki, E., Ψαλτοπούλου, Θ., & Paschou, S. Α. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261457548
Clinician-Level Variation in MAUD Prescribing: The Role of Behavioral Health Experience
Friedman, S. A., Guo, Y., Owen, L., Chien, L.-C., Woodard, S., & Keller, M. S. (2026) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-026-09998-y
Brain Penetrant Calcium Channel Blockers Were Not Associated With Reduced Alcohol Consumption: Converging Results From Two Large Independent Cohort Studies Using Electronic Health Records
Rentsch, C. T., Palzes, V. A., Shi, M., Setzer, M. R., Malone, S. G., Kline‐Simon, A. H., Piserchia, Z., Winterlind, E. L., Leggio, L., Re, V. L., et al. (2026) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70487 · Cited by 1
Acute Alcohol-Associated Hepatitis: The Role of Liver Transplantation
Khan, A. M., & Malik, S. M. (2026) · Journal of Intensive Care Medicine · doi:10.1177/08850666261498029

Authors: Reus, V. I., Fochtmann, L. J., Bukstein, O., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Mahoney, J., Pasic, J., Weaver, M., Wills, C. D., McIntyre, J., Kidd, J., Yager, J., & Hong, S.-H.
Affiliations: From the APA Practice Guideline Writing Group (Victor I. Reus, M.D., Chair)
ORCID: Reus, Victor I.
Fochtmann, Laura J.
Hilty, Donald M.
Horvitz-Lennon, Marcela
Weaver, Michael
Kidd, Jeremy
Yager, Joel
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 2018-01-01
Volume: 175
Issue: 1
Pages: 86-90
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/appi.ajp.2017.1750101
OpenAlex: W2782206210
Cited by: 372
References: 20
Citations by year: 2026: 40 · 2025: 50 · 2024: 57 · 2023: 70 · 2022: 41 · 2021: 37 · 2020: 28 · 2019: 27 · 2018: 17
FWCI: 21.28
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords: alcoholism, pharmacotherapy, treatment guidelines
MeSH terms: Alcoholism, Humans, Patient Care Management, Psychological Techniques, Psychotropic Drugs, United States, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks